NDC 13985-701 - MotaZol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-701
- Package NDCs from labels
- 13985-701-07, 13985-701-15, 13985-701-30, 13985-701-21
- Manufacturer
- MWI
- Effective date
- 2024-11-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MotaZol - MWI | MWI | 2024-11-15 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-701-07 | MotaZol | 7.5 g in 1 BOTTLE, DISPENSING | SUSPENSION | 7.5 | 7 | |
| 13985-701-07 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-15 | MotaZol | 15 g in 1 BOTTLE, DISPENSING | SUSPENSION | 15 | 7 | |
| 13985-701-15 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-21 | MotaZol | 215 g in 1 BOTTLE, PLASTIC | SUSPENSION | 215 | 7 | |
| 13985-701-21 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-30 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-30 | MotaZol | 30 g in 1 BOTTLE, DISPENSING | SUSPENSION | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Clotrimazole | ACTIVE INGREDIENT | G07GZ97H65 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Gentamicin Sulfate | ACTIVE INGREDIENT | 8X7386QRLV | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Mometasone Furoate Monohydrate | ACTIVE INGREDIENT | MTW0WEG809 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Clotrimazole | ACTIVE MOIETY | G07GZ97H65 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Gentamicin | ACTIVE MOIETY | T6Z9V48IKG | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Mometasone | ACTIVE MOIETY | 8HR4QJ6DW8 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | 80d67df3-843d-47bb-85a2-d2f26a824336 | 2026-03-31 | Warnings | G07GZ97H65 |
| RoyceDerm Antifungal Bar | CLOTRIMAZOLE | RoyceDerm LLC | 3abdc4a8-58dd-5bd0-e063-6294a90a1bca | 2026-03-31 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals, Inc. | 624827d6-dbf8-4f3d-a8c0-c92474cad7de | 2026-03-31 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | fd010006-f646-46ed-841a-9f247b19e397 | 2026-03-31 | Warnings | G07GZ97H65 |
| allergy | MOMETASONE FUROATE MONOHYDRATE | HyVee Inc | 9f83880b-0062-433a-bc4a-00886b975dd3 | 2026-03-29 | Warnings | MTW0WEG809 |
| Lasolex Liquid Solution | CLOTRIMAZOLE 1% | PureTek Corporation | 4dc9e64d-8235-b218-e063-6394a90a0157 | 2026-03-24 | Warnings | G07GZ97H65 |
| seebeellar clotrimazole 1% antifungal cream | SEEBEELLAR CLOTRIMAZOLE 1% ANTIFUNGAL CREAM | GUANGZHOU YUSONG FINE CHEMICLS Co., Ltd | 4d80e551-76c2-150a-e063-6394a90a7996 | 2026-03-20 | Warnings | G07GZ97H65 |
| Clotrimazole Topical Solution USP, 1% | CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% | Bryant Ranch Prepack | 6a50410d-ef84-4b60-9bec-cf1d1166e461 | 2026-03-19 | Warnings, Adverse reactions | G07GZ97H65 |
| Antifungal | CLOTRIMAZOLE | Dynarex Corporation | 4d4cc4b4-c0b4-9e25-e063-6294a90a70b8 | 2026-03-18 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate Opth Solution | GENTAMICIN SULFATE OPTH SOLUTION | Direct_Rx | e1a5bc32-f9a0-6b33-e053-2995a90ab9ac | 2026-03-17 | Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole/Betameth | CLOTRIMAZOLE/BETAMETH | Direct_Rx | 08901233-7d36-e5d9-e063-6394a90af33d | 2026-03-17 | Warnings, Adverse reactions | G07GZ97H65 |
| Tuymec Antifungal Medicated Bar | ANTIFUNGAL MEDICATED BAR | Guangzhou Jingliang Cosmetics Co., Ltd. | 4cb6fdfd-116e-14e9-e063-6294a90a4de3 | 2026-03-10 | Warnings | G07GZ97H65 |
| Tuymec Antifungal Medicated Bar | ANTIFUNGAL MEDICATED BAR | Guangzhou Jingliang Cosmetics Co., Ltd. | 4cb73ebe-f9bb-5a8d-e063-6294a90a3c2b | 2026-03-10 | Warnings | G07GZ97H65 |
| allergy nasal | MOMETASONE FUROATE MONOHYDRATE | Walgreen Company | 9f28b399-0035-4753-8d1b-ddea212f86e8 | 2026-03-06 | Warnings | MTW0WEG809 |
| RoyceDerm ANTIFUNGAL .soap. | CLOTRIMAZOLE 1% | RoyceDerm LLC | 4c43e62b-9060-8962-e063-6394a90aff63 | 2026-03-05 | Warnings | G07GZ97H65 |
| CLOTIC (clotrimazole) otic solution | CLOTRIMAZOLE | Carwin Pharmaceutical Associates, LLC | ef0658c3-9c6b-4705-89d8-cf0644c80fcb | 2026-03-03 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | TRIFECTA PHARMACEUTICALS USA LLC | e0a2a907-9c3a-4c4e-e053-2995a90abb91 | 2026-03-01 | Warnings | G07GZ97H65 |
| CLOTRIMAZOLE | CLOTRIMAZOLE | AARNA USA INC | 4bd825f4-f5e2-aab7-e063-6394a90ad6a4 | 2026-02-27 | Warnings, Adverse reactions | G07GZ97H65 |
| Megababe Fun Gal Stuff Antifungal | CLOTRIMAZOLE | Megababe LLC | c599d27b-fdb0-465f-9e43-13d32c520a92 | 2026-02-25 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | d6f5c6b5-5e56-462f-8c47-7986ce53669d | 2026-02-25 | Warnings | G07GZ97H65 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.